Making a Difference? brings together medical humanities and sciences experts to analyze how historical and new data on typhoid control can be brought to bear on the current context of typhoid conjugate vaccine rollouts and extensively drug-resistant typhoid.
Typhoid fever is an ancient companion of humanity. Caused by the human-specific gram-negative pathogen Salmonella enterica serovar Typhi (S. Typhi) and spread by contaminated water, food, and asymptomatic carriers, typhoid has historically been presented as a scourge of armies and cities and as a killer of kings and paupers [1] . While typhoid has vanished from most high-income countries, it remains endemic in many low-and middle-income countries (LMICs). Despite the long tradition of scientific interest in typhoid, typhoid control has not attracted the same level of funding and public attention as other, more prominent diseases like the "big 3": human immunodeficiency virus/AIDS, tuberculosis, and malaria [2, 3] . After decades of relative political neglect, extensively drug-resistant (XDR) S. Typhi strains and new conjugate vaccines are causing a resurgence of scientific, commercial, governmental, and nongovernmental interest in typhoid control [4] .
But how should typhoid control be structured? Combining current research with an analysis of past interventions offers a way forward. In the 163 years since William Budd's first article on waterborne typhoid transmission was published [5] , numerous typhoid interventions have been implemented across the world. Not every intervention was successful, and some successful interventions may no longer be appropriate in times of spreading antimicrobial resistance (AMR) and climate change. However, others may still prove useful.
Making a Difference? results from a 2018 international workshop in Oxford, which brought together medical humanities and sciences experts, international donors, and policymakers to assess historical and contemporary aspects of typhoid control. The joint-authored articles in Making a Difference? make an important contribution to current debates about typhoid control and highlight the potential of using interdisciplinary approaches to study major global health challenges. While the supplement's historical and current case studies show that there is no universal roadmap for typhoid control, robust international strategies should be multipronged, locally tailored, and pair the long-term strengthening of national LMIC surveillance and healthcare capabilities with enhanced funding for new technical interventions such as vaccines, community engagement of local populations, and the provision of affordable credit for ownership and sustainable maintenance of clean water and sanitation infrastructures at the municipal level.
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